In this episode of Chasing Compliance, Linda Peterson, Sarah Schaul, and Kari Gibney discuss how to maximize the relationship with your CRO from the Sponsor’s and Site’s perspectives. Each member of the panel shares their thoughts on what makes a CRO great and why communication, flexibility, and teamwork are essential. The show wraps up with some important, but rarely considered, tips for maximizing the relationship with your CRO.
Linda Peterson is the VP of Clinical Development at Global. For over a decade, Linda has been leading clinical trials, directing clinical departments, and working with all involved in clinical trials. Sarah Schaul is a Clinical Trial Manager at Global. Sarah started her research career at the bench and transitioned into clinical research several years ago. She has worked on the site side and the sponsor side and now leads clinical studies for Global. Kari Gibney’s primary appointment is at the University of Colorado Anschutz Medical Campus as a Clinical Research Coordinator. For the last 5 years Kari has been a core piece of the clinical research team in the School of Medicine and the Department of Oncology at the University.
2:00 What Is A Clinical Research Organization (CRO)
3:30 Do CROs Speed Up Research?
7:50 Stories of Less-Than-Ideal CRO-Sponsor Interactions
11:20 A Great CRO From the CRC’s Perspective
14:10 The Importance of Communication
19:50 Examples Poor Communication and The Importance of Communication
25:30 Tips for Maximizing the Interaction with A CRO
34:10 Flexibility and Communication vs Micromanagement – Tips for Making a Change
40:20 Final Thoughts on Managing the Relationship with a CRO and Favorite Fridays
In this episode of Chasing Compliance, host Jamie Hijmans sits down with Carrie Eklund, Senior Manager of Chemistry, Manufacturing, and Controls or CMC at...
This episode of Chasing Compliance features two first-hand accounts of what it was like to participate in the Global Clinical Evaluation Report (CER) Internship...
In this episode of Chasing Compliance, Jamie talks with Brandi Quinlin and Rebecca Lynch about generic drugs. The discussion ranges from what a generic...